These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 10447444)

  • 41. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.
    Palareti G; Legnani C; Cosmi B; Valdré L; Lunghi B; Bernardi F; Coccheri S
    Circulation; 2003 Jul; 108(3):313-8. PubMed ID: 12847064
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [There is evidence for prolonged low-intensity warfarin therapy after venous thrombosis].
    Schulman S
    Lakartidningen; 2003 Jun; 100(24):2118-21. PubMed ID: 12841107
    [No Abstract]   [Full Text] [Related]  

  • 43. Anticoagulation in the antiphospholipid syndrome.
    Casais P; Alberto MF; Gennari LC; Grosso SH; Meschengieser SS; Lazzari MA
    Haematologica; 2004 Apr; 89(4):503-4. PubMed ID: 15075090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A synthetic pentasaccharide for the prevention of deep-vein thrombosis.
    Hull R; Pineo G
    N Engl J Med; 2001 Jul; 345(4):291; author reply 292. PubMed ID: 11474672
    [No Abstract]   [Full Text] [Related]  

  • 45. Idiopathic venous thrombosis. Long-term anticoagulant therapy? No.
    Kyrle PA
    Hamostaseologie; 2006 Jan; 26(1):52-4. PubMed ID: 16444323
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in the safety profiles of two low-molecular-weight heparins.
    Ofosu FA
    Thromb Haemost; 2008 Jun; 99(6):989-90. PubMed ID: 18521496
    [No Abstract]   [Full Text] [Related]  

  • 47. Thrombophilic abnormalities and recurrence of venous thromboembolism in patients treated with standardized anticoagulant treatment.
    Santamaria MG; Agnelli G; Taliani MR; Prandoni P; Moia M; Bazzan M; Guazzaloca G; Ageno W; Bertoldi A; Silingardi M; Tomasi C; Ambrosio GB;
    Thromb Res; 2005; 116(4):301-6. PubMed ID: 16038714
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Thrombophilic disorders in venous thromboembolism. The clinical perspective].
    Schmidt B; Schellong S
    Med Klin (Munich); 2003 Mar; 98(3):133-9. PubMed ID: 12647087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Optimal duration of anticoagulation in idiopathic venous thromboembolism should be determined by multiple variables.
    Oo TH
    J R Coll Physicians Edinb; 2011 Mar; 41(1):91-2. PubMed ID: 21365074
    [No Abstract]   [Full Text] [Related]  

  • 50. Optimal duration of anticoagulation after venous thromboembolism: fixed and evidence-based, or flexible and personalized?
    Goldhaber SZ
    Ann Intern Med; 2009 May; 150(9):644-6. PubMed ID: 19414845
    [No Abstract]   [Full Text] [Related]  

  • 51. Direct oral anticoagulants in antiphospholipid syndrome.
    Carvalho JF; Andrade DC; Levy RA
    Rev Bras Reumatol Engl Ed; 2016; 56(6):469-470. PubMed ID: 27914591
    [No Abstract]   [Full Text] [Related]  

  • 52. [Hot topic: direct oral anticoagulants (DOAC) in antiphospholipid syndrome?].
    Specker C; Dörner T; Schneider M
    Z Rheumatol; 2019 Aug; 78(6):493-494. PubMed ID: 31197460
    [No Abstract]   [Full Text] [Related]  

  • 53. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
    Paul N
    N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14695423
    [No Abstract]   [Full Text] [Related]  

  • 54. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
    Gelber AC; Saleh AS
    N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699652
    [No Abstract]   [Full Text] [Related]  

  • 55. Venous thrombosis in the antiphospholipid syndrome.
    Farmer-Boatwright MK; Roubey RA
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):321-5. PubMed ID: 19228605
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Venous thromboembolism: risk factors for recurrence.
    Zhu T; Martinez I; Emmerich J
    Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):298-310. PubMed ID: 19228602
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Anticoagulation for venous thromboembolism.
    Khamashta MA; Williams FM; Hunt BJ
    N Engl J Med; 1999 Aug; 341(7):539-40. PubMed ID: 10447444
    [No Abstract]   [Full Text] [Related]  

  • 58. Warfarin prophylaxis in the antiphospholipid antibody syndrome.
    Stern SD
    N Engl J Med; 2003 Dec; 349(26):2568-70; author reply 2568-70. PubMed ID: 14699650
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.